249 related articles for article (PubMed ID: 20670131)
61. Enhancer of zeste homolog 2 expression is associated with metastasis and adverse clinical outcome in clear cell renal cell carcinoma: a comparative study and review of the literature.
Xu B; Abourbih S; Sircar K; Kassouf W; Mansure JJ; Aprikian A; Tanguay S; Brimo F
Arch Pathol Lab Med; 2013 Oct; 137(10):1326-36. PubMed ID: 24079759
[TBL] [Abstract][Full Text] [Related]
62. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
[TBL] [Abstract][Full Text] [Related]
63. Clinicopathological, genetic, ultrastructural characterizations and prognostic factors of papillary renal cell carcinoma: new diagnostic and prognostic information.
Yu W; Zhang W; Jiang Y; Wang Y; Li Y; Wang J; Sun L; Ran W; Li H
Acta Histochem; 2013 Jun; 115(5):452-9. PubMed ID: 23219441
[TBL] [Abstract][Full Text] [Related]
64. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
[TBL] [Abstract][Full Text] [Related]
65. Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms.
Gonzalez-Roibon N; Faraj SF; Munari E; Bezerra SM; Albadine R; Sharma R; Argani P; Allaf ME; Netto GJ
Hum Pathol; 2014 Feb; 45(2):244-8. PubMed ID: 24315206
[TBL] [Abstract][Full Text] [Related]
66. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
67. Immunohistochemical detection of the von Hippel-Lindau gene product (pVHL) in human tissues and tumors: a useful marker for metastatic renal cell carcinoma and clear cell carcinoma of the ovary and uterus.
Lin F; Shi J; Liu H; Zhang J; Zhang PL; Wang HL; Yang XJ; Schuerch C
Am J Clin Pathol; 2008 Apr; 129(4):592-605. PubMed ID: 18343787
[TBL] [Abstract][Full Text] [Related]
68. Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT.
Young JR; Young JA; Margolis DJA; Sauk S; Sayre J; Pantuck AJ; Raman SS
Acad Radiol; 2017 Oct; 24(10):1226-1232. PubMed ID: 28528853
[TBL] [Abstract][Full Text] [Related]
69. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
[TBL] [Abstract][Full Text] [Related]
70. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
71. Cadherin-6 gene expression in conventional renal cell carcinoma: a useful marker to detect circulating tumor cells.
Li G; Passebosc-Faure K; Gentil-Perret A; Lambert C; Genin C; Tostain J
Anticancer Res; 2005; 25(1A):377-81. PubMed ID: 15816561
[TBL] [Abstract][Full Text] [Related]
72. Diagnostic utility of renal cell carcinoma marker in cytopathology.
Gokden N; Mukunyadzi P; James JD; Gokden M
Appl Immunohistochem Mol Morphol; 2003 Jun; 11(2):116-9. PubMed ID: 12777993
[TBL] [Abstract][Full Text] [Related]
73. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients.
Thompson LDR; Magliocca KR; Andreasen S; Kiss K; Rooper L; Stelow E; Wenig BM; Bishop JA
Head Neck Pathol; 2019 Sep; 13(3):355-363. PubMed ID: 30291511
[TBL] [Abstract][Full Text] [Related]
74. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
[TBL] [Abstract][Full Text] [Related]
75. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution.
Paner GP; Srigley JR; Radhakrishnan A; Cohen C; Skinnider BF; Tickoo SK; Young AN; Amin MB
Am J Surg Pathol; 2006 Jan; 30(1):13-9. PubMed ID: 16330937
[TBL] [Abstract][Full Text] [Related]
76. Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center.
Gill S; Kauffman EC; Kandel S; George S; Schwaab T; Xu B
Int J Surg Pathol; 2016 May; 24(3):207-12. PubMed ID: 26510859
[TBL] [Abstract][Full Text] [Related]
77. Expression of E- and N-cadherin in renal cell carcinomas, in renal cell carcinoma cell lines in vitro and in their xenografts.
Tani T; Laitinen L; Kangas L; Lehto VP; Virtanen I
Int J Cancer; 1995 Dec; 64(6):407-14. PubMed ID: 8550243
[TBL] [Abstract][Full Text] [Related]
78. Immunohistochemical study of c-KIT (CD117) expression in renal cell carcinoma.
Ahmed EA; Youssif ME
J Egypt Natl Canc Inst; 2009 Jun; 21(2):121-32. PubMed ID: 21057563
[TBL] [Abstract][Full Text] [Related]
79. Prognostic role of CD44 cell adhesion molecule expression in primary and metastatic renal cell carcinoma: a clinicopathologic study of 125 cases.
Lim SD; Young AN; Paner GP; Amin MB
Virchows Arch; 2008 Jan; 452(1):49-55. PubMed ID: 18026989
[TBL] [Abstract][Full Text] [Related]
80. Different DNA ploidy patterns for the differentiation of common subtypes of renal tumors.
Li G; Cottier M; Sabido O; Gentil-Perret A; Lambert C; Genin C; Tostain J
Cell Oncol; 2005; 27(1):51-6. PubMed ID: 15750207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
